title: Antithrombotic medicines following intracerebral haemorrhage: where's the evidence?
abstract: The use of antithrombotic medicines in patients who have a history of intracerebral haemorrhage is widely perceived as being contraindicated. However, many patients with intracerebral haemorrhage may suffer from conditions for which antithrombotic medicines are indicated. Such scenarios represent a therapeutic dilemma whereby treating infers an increased risk of recurrent intracerebral haemorrhage, but not treating infers an increase of thrombotic complications. Despite the importance of this dilemma, there is very little guidance for prescribers. This perspective review considered previous systematic reviews that addressed this issue, together with recently published research findings from the Tayside Stroke Cohort. Systematic reviews of experimental and observational studies have concluded that there is a marked lack of data on which to judge the safety of oral anticoagulant agents following intracerebral haemorrhage. In addition, the limited data available regarding the use of antiplatelet medicines following intracerebral haemorrhage provide no evidence that they are harmful, and again further data are required. In the absence of such data, a decision analysis approach has been proposed. This considers the findings of other studies to infer the likely impact of using antithrombotic agents in patients with intracerebral haemorrhage. The success of this approach is contingent on the availability of reliable data that describe the rate of recurrent intracerebral haemorrhage; however, published data on this varies widely. There are a number of factors that conspire against researchers addressing this issue. The current paucity of evidence to guide prescribers faced with this therapeutic dilemma seems likely to remain for some time.
authors.affiliation: Medicines Monitoring Unit, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK.
authors.forename: Robert
authors.initials: R
authors.lastname: Flynn
authors.affiliation: Centre for Cardiovascular & Lung Biology, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
authors.forename: Alexander
authors.initials: A
authors.lastname: Doney
keywords: anticoagulants; cerebral haemorrhage; cohort studies; hematologic agents; platelet aggregation inhibitors; recurrence
references.citation: Stroke. 2003 Jul;34(7):1710-6
references.pmid: 12805495
references.citation: Mayo Clin Proc. 2007 Jan;82(1):82-92
references.pmid: 17285789
references.citation: Stroke. 2010 Sep;41(9):2005-9
references.pmid: 20651265
references.citation: Curr Opin Neurol. 2011 Feb;24(1):69-74
references.pmid: 21124218
references.citation: N Engl J Med. 2000 Jan 27;342(4):240-5
references.pmid: 10648765
references.citation: J Neurol Neurosurg Psychiatry. 2005 Nov;76(11):1534-8
references.pmid: 16227546
references.citation: Stroke. 2003 Nov;34(11):e217-8; author reply e217-8
references.pmid: 14563956
references.citation: J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):836-40
references.pmid: 17220294
references.citation: Neurology. 2002 Jul 23;59(2):205-9
references.pmid: 12136058
references.citation: Stroke. 2007 Jun;38(6):2001-23
references.pmid: 17478736
references.citation: Health Technol Assess. 2004 Jan;8(1):iii, ix-x, 1-180
references.pmid: 14731377
references.citation: Stroke. 2006 Oct;37(10):2493-8
references.pmid: 16931783
references.citation: Stroke. 2010 Nov;41(11):2606-11
references.pmid: 20947854
references.citation: Arch Intern Med. 1997 Nov 24;157(21):2413-46
references.pmid: 9385294
references.citation: Circulation. 2007 Feb 6;115(5):e69-171
references.pmid: 17194875
references.citation: Neurology. 2006 Jan 24;66(2):206-9
references.pmid: 16434655
references.citation: Curr Treat Options Cardiovasc Med. 2003 Jul;5(3):201-209
references.pmid: 12777198
references.citation: J Hypertens. 1998 Jun;16(6):747-52
references.pmid: 9663914
references.citation: J Intern Med. 2003 Nov;254(5):434-8
references.pmid: 14535964
references.citation: Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):843-7
references.pmid: 20602346
references.citation: Cardiovasc Ther. 2010 Jun;28(3):177-84
references.pmid: 20337638
references.citation: Neurology. 2001 Mar 27;56(6):773-7
references.pmid: 11274313
references.citation: Pharmacoepidemiol Drug Saf. 2010 Jul;19(7):737-44
references.pmid: 20583205
references.citation: Nat Clin Pract Neurol. 2006 Sep;2(9):480-1
references.pmid: 16932612
references.citation: BMJ. 2005 Aug 20;331(7514):439-42
references.pmid: 16110073